que es el bpc 157 Peptide BPC-157 The Hidden Risks of BPC‑157:

Neurological: convulsions, increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatment, vertigo, headache Endocrine: menstrual irregularities, development of cushingoid state, suppression of fetal intrauterine or childhood growth, lack of secondary response of the adrenal cortex or pituitary gland, particularly in situations of stress such as trauma, surgery or illness, decreased carbohydrate tolerance, manifestations of latent diabetes mellitus, increased requirements of insulin or oral hypoglycemic agents in diabetic patients Ophtalmic: posterior subcapsular cataracts, increased intraocular pressure, glaucoma, exophthalmos Metabolic: negative nitrogen balance due to protein catabolism Psychiatric: euphoria, mood swings, severe depression to frank psychotic manifestations, personality changes, hyperirritability, insomnia Others: anaphylactoid or hypertensive reactions and hypotension or shock-like reaction Cyanocobalamin and hydroxocobalamin: hypervitaminosis and side effects were not observed with their use Dosage and administration Adults Coated tablets: 1 coated tablet 2 times a day

Eating foods high in calcium (such as milk, tuna, salmon, eggs and dark leafy greens) is a good idea, but additional supplementation may be necessary to prevent or slow bone loss

Reconstitution reference U100 units to draw for each common BPC-157 dose, by vial size, reconstituted with 2 mL of bacteriostatic water

Benefits are typically more noticeable when correcting an existing deficiency

48 (3 Suppl): 852858

Injections of Neurobion aid in the prevention or treatment of vitamin B deficiency